Hydroxychloroquine is classified as a disease-modifying antirheumatic drug (DMARD) due to its ability to slow disease progression and reduce inflammation in autoimmune conditions.
plaquenil 200mg It is often prescribed as part of a comprehensive treatment regimen that may include other DMARDs, corticosteroids, or nonsteroidal anti-inflammatory drugs (NSAIDs). The combination of these medications aims to control symptoms, prevent joint damage, and improve overall quality of life for patients with rheumatic diseases.